Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: A nationwide survey in Japan

Pediatric Blood and Cancer

Volumn 59, Issue 1, 2012, Pages 110-114

  Asano, Takeshi ^a,b   Kogawa, Kazuhiro ^b   Morimoto, Akira ^b   Ishida, Yasushi ^b   Suzuki, Nobuhiro ^b   Ohga, Shouichi ^b   Kudo, Kazuko ^b   Ohta, Shigeru ^b   Wakiguchi, Hiroshi ^b   Tabuchi, Ken ^c   Kato, Shunichi ^c   Ishii, Eiichi ^b  

^a NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^b HLH/LCH Committees in the Japanese Society of Pediatric Hematology   (Japan)

^c Japanese Society of Pediatric Hematology   (Japan)

Author keywords

Children; Hematopoietic stem cell transplantation; Hemophagocytic lymphohistiocytosis; Japan; Nationwide Survey

Indexed keywords

BILIRUBIN; CORTICOSTEROID; CYCLOSPORIN; ETOPOSIDE; FERRITIN; IMMUNOGLOBULIN; INTERLEUKIN 2; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TRIACYLGLYCEROL;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOVIRUS INFECTION; APLASTIC ANEMIA; ARTICLE; CANCER RELAPSE; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; CHRONIC LEUKEMIA; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CONVULSION; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DISEASE COURSE; DISEASE SURVEILLANCE; EPSTEIN BARR VIRUS INFECTION; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOBLASTOMA; HEPATOMEGALY; HUMAN; HYPERFERRITINEMIA; HYPERLIPIDEMIA; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; KIDNEY FAILURE; LABORATORY TEST; MALE; MULTIPLE ORGAN FAILURE; MYELODYSPLASTIC SYNDROME; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; ONSET AGE; PLASMAPHERESIS; PRIORITY JOURNAL; RHABDOMYOSARCOMA; RISK ASSESSMENT; SKIN DISEASE; SPLENOMEGALY; SUBARACHNOID HEMORRHAGE; SURVIVAL RATE; WHOLE BODY RADIATION;

ANEMIA, APLASTIC; BILIRUBIN; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; JAPAN; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; NEOPLASMS; QUESTIONNAIRES; SURVIVAL RATE; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS; TRIGLYCERIDES;

EID: 84861205228     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23384     Document Type: Article

References (21)

1. Janka GE. Familial and acquired hemophagocytic lymphocytosis. Eur J Pediatr 2007; 166: 95-109.
2. Ishii E, Ohga S, Imashuku S, et al. Nationwide Survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007; 86: 58-65.
3. + T cells and interferon gamma are essential for the disorder. Blood 2004; 104: 735-743.
4. Billiau AD, Roskams T, Van Damme-Lombaerts R, et al. Macrophage activation syndrome: Characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6 and TNF-alpha-producing macrophages. Blood 2005; 105: 1648-1651.
5. Koyama M, Sawada A, Yasui M, et al. Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogenic hematopoietic stem cell transplantation. Int J Hematol 2007; 86: 466-467.
6. Levy J, Wodell RA, August CS, Bayever E. Adenovirus-related hemophagocytic syndrome after bone marrow transplantation. Bone Marrow Transplant 1990; 6: 349-352.
7. Sato M, Matsushima T, Takada S, et al. Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation. Bone Marrow Transplant 1998; 22: 1219-1222.
8. Tanaka T, Matsubara H, Adachi S, et al. Second transplantation from HLA 2-loci-mismatched mother for graft failure due to hemophagocytic syndrome after cord blood transplantation. Int J Hematol 2004; 80: 467-469.
9. Ishida H, Yoshida H, Yoshihara T, et al. Origin of macrophages involved in the development of allogenic hematologic stem cell transplantation-associated hemophagocytic syndrome: Observations on a patient with juvenile myelomonocytic leukemia. Bone Marrow Transplant 2007; 40: 701-703.
10. Hashii Y, Yoshida H, Kuroda S, et al. Hemophagocytosis after bone marrow transplantation for JAK3-deficient severe combined immunodeficiency. Pediatr Transplant 2010; 14: E105-E109.
11. Lackner H, Urban C, Sovinz P, et al. Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children. Haematologica 2008; 93: 291-294.
12. Imashuku S. Differential diagnosis of hemophagocytic syndrome: Underlying disorders and selection of the most effective treatment. Int J Hematol 1997; 66: 135-151.
13. Henter J-I, Horne AC, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.
14. Filipovich A. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematol Am Soc Hematol Educ Program 2009; 127-131.
15. Imashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 1997; 130: 352-357.
16. Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 1989; 72: 2128-2132.
17. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893-898.
18. Goddard DS, Horn BN, McCalmont TH, Cordoro KM. Clinical update on graft versus-host disease in children. Semin Cutan Med Surg 2010; 29: 92-105.
19. Rodriguez R, Nakamura R, Palmer JM, et al. A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. Blood 2010; 115: 1098-1105.
20. Yagasaki H, Kojima S, Yabe H, et al. Tacrolimus/methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: Results of matched pair analysis. Biol Blood Marrow Transplant 2009; 15: 1603-1608.
21. Keates-Baleeiro J, Moore P, Koyama T, et al. Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients. Bone Marrow Transplant 2006; 38: 285-289.